Novavax NVAX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85%-8.5pp | 93.5%+1.7pp | 91.8%+3.5pp | 88.3%+0.8pp | 87.4%+17.2pp | |
| Operating margin | -13.1%-53.4pp | 40.3%+11.4pp | 28.9%-3.7pp | 32.6%-0.2pp | 32.8%+69.3pp | |
| Net margin | -14.7%-53.9pp | 39.2%+7.1pp | 32.1%-7.1pp | 39.2%+1.1pp | 38.1%+65.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.3× | 0.8×+0.1× | 0.7×+0.1× | 0.7×-0.3× | 0.9×+0.5× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.4× | 2.1×-0.1× | 2.3×-0.1× | 2.4×+0.3× | 2.1×+1.1× | |
| Per Share | ||||||
| Book value per share | -$0.89-20.1% | -$0.74+23.5% | -$0.97-555% | $0.21+150% | -$0.43+89.6% | |
| Valuation | ||||||
| Market capitalization | $1.46B+41.0% | $1.09B-22.5% | $1.41B+34.0% | $1.05B+2.0% | $1.03B-19.9% | |
| Price / sales | 2.5×+1.6× | 1×-0.4× | 1.3×+0.3× | 1×+0.2× | 0.8×-1.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's profit margins?
- Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
- Where do Novavax's ratios come from?
- Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
